key: cord-0780858-owne315y
authors: Valdes, Eduard; Fuchs, Benjamin; Morrison, Chris; Charvet, Leigh; Lewis, Ariane; Thawani, Sujata; Balcer, Laura; Galetta, Steven L.; Wisniewski, Thomas; Frontera, Jennifer A.
title: Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19
date: 2022-01-07
journal: J Neurol Sci
DOI: 10.1016/j.jns.2022.120146
sha: 22d16a90647b26b9684d59dcd89e5dc912b1870a
doc_id: 780858
cord_uid: owne315y

BACKGROUND: Persistent cognitive symptoms have been reported following COVID-19 hospitalization. We investigated the relationship between demographics, social determinants of health (SDOH) and cognitive outcomes 6-months after hospitalization for COVID-19. METHODS: We analyzed 6-month follow-up data collected from a multi-center, prospective study of hospitalized COVID-19 patients. Demographic and SDOH variables (age, race/ethnicity, education, employment, health insurance status, median income, primary language, living arrangements, and pre-COVID disability) were compared between patients with normal versus abnormal telephone Montreal Cognitive Assessments (t-MOCA; scores<18/22). Multivariable logistic regression models were constructed to evaluate predictors of t-MoCA. RESULTS: Of 382 patients available for 6-month follow-up, 215 (56%) completed the t-MoCA (n = 109/215 [51%] had normal and n = 106/215 [49%] abnormal results). 14/215 (7%) patients had a prior history of dementia/cognitive impairment. Significant univariate predictors of abnormal t-MoCA included older age, ≤12 years of education, unemployment pre-COVID, Black race, and a pre-COVID history of cognitive impairment (all p < 0.05). In multivariable analyses, education ≤12 years (adjusted OR 5.21, 95%CI 2.25–12.09), Black race (aOR 5.54, 95%CI 2.25–13.66), and the interaction of baseline functional status and unemployment prior to hospitalization (aOR 3.98, 95%CI 1.23–12.92) were significantly associated with abnormal t-MoCA scores after adjusting for age, history of dementia, language, neurological complications, income and discharge disposition. CONCLUSIONS: Fewer years of education, Black race and unemployment with baseline disability were associated with abnormal t-MoCA scores 6-months post-hospitalization for COVID-19. These associations may be due to undiagnosed baseline cognitive dysfunction, implicit biases of the t-MoCA, other unmeasured SDOH or biological effects of SARS-CoV-2.

such as hypoxia, hyperinflammation, hypercoagulability, blood brain barrier disruption, uremia, septic encephalopathy or autoimmune mechanisms 17 . Beyond these biological effects, extensive literature also suggests a role for sociodemographic factors-including race, ethnicity, education, healthcare access and economic environment-in modulating cognitive outcomes and recovery following hospitalization [18] [19] [20] [21] . Additionally, pandemic-related lockdowns, school closures and economic stressors appear to contribute to both mental health and cognitive sequelae 22, 23 . In the context of COVID-19, racial/ethnic disparities and other social determinants of health (SDOH) have been linked to higher rates of SARS-CoV-2 infection, severity of illness and mortality rates [24] [25] [26] . However, the role that SDOH may play in the development of PASC-related cognitive dysfunction has not been addressed.

In this study, we evaluated the relationship between demographics, SDOH and cognitive outcomes 6-months after index COVID-19 hospitalization. We further characterized the subdomains of cognitive dysfunction within this patient cohort. We hypothesized that racial/ethnic minority groups, patients with less access to the health care system, and those with lower education levels would have higher rates of cognitive deficits following severe COVID-

Participants: Consecutive COVID-19 patients hospitalized in the New York City metropolitan area between March 10, 2020 and May 20, 2020 were prospectively screened for new neurological events by a team of neurologists. 16, 27 We then conducted 6-month telephone follow-up interviews in patient populations with and without new neurological events during hospitalization. Patients underwent batteries which included cognitive, functional and neuropsychiatric assessments.

Inclusion criteria were: age ≥18 years, hospital admission for COVID-19 illness, reversetranscriptase-polymerase-chain-reaction (RT-PCR) positive SARS-CoV-2 infection from nasopharyngeal sampling, and consent to participate in a follow-up interview. Exclusion criteria were: negative or missing SARS-CoV-2 RT-PCR test, in-hospital death outpatient or emergency department encounter only or inability to complete the t-MOCA assessment. Detailed screening and data acquisition protocols have been reported previously 16, 27 . Patients were characterized as having a new neurological complication during hospitalization following acute SARS-CoV-2 infection (excluding recrudescence of prior neurological symptoms) based on evaluation of a board-certified neurologist. Neurological diagnosesincluding toxic-metabolic encephalopathy, hypoxic-ischemic encephalopathy, stroke (ischemic or hemorrhagic), seizure, neuropathy, myopathy, movement disorder, encephalitis/meningitis, myelopathy, myelitis-followed established criteria 28-37 .

Telephone interviews were conducted to obtain longitudinal 6-month follow-up assessments, as previously described 16 . Contact was attempted at 6-months (±1 month) from COVID-19 diagnosis. Three attempts at contact were required before patients/surrogates were coded as "unreachable". Demographic variables included: age, sex, race, ethnicity and zip code. SDOH variables included: health insurance status, median income, education level, non-fluency in English, employment status, living arrangements, disability status (as measured by the mRS) and marital status. Demographics, past medical history, hospital course, and discharge disposition were collected through review of medical records. Race, ethnicity, education, employment, primary language and non-fluency in the dominant language of the region, marital status and living arrangements (alone, with family, nursing home, rehabilitation center or other institution) were reported by the patient or their surrogate. A past history of dementia was coded for patients with pre-existing diagnoses of mild cognitive impairment, Alzheimer's type dementia, vascular dementia, Lewy body/Parkinson's related dementia, progressive supranuclear palsy, multiple system atrophy, corticobasal degeneration, frontal-temporal dementia, normal pressure hydrocephalus or Creutzfeld-Jakob disease. Pre-morbid baseline modified Rankin scale scores (mRS scores 38 ) were collected based on patient/surrogate report at the 6-month interview 16 . Pre-COVID-19 employment status was categorized as: retired, part-time employment, full-time employment, not employed, student or other. Unemployment pre-COVID was coded only for subjects who described themselves as "not employed", excluding retired subjects and students.

Median income was determined by zip code and obtained from online databases for New York City 39, 40 and Nassau counties 41 .

We administered the Telephone/Blind Montreal Cognitive Assessment 42 (t-MoCA: 22=perfect score; <18=cutoff for cognitive impairment) in the primary language for each patient using standardized forms (English, Spanish, Chinese, and Russian). Interviews were conducted J o u r n a l P r e -p r o o f Journal Pre-proof over the phone by trained physicians and medical students who were native speakers or trained translators of the patient's primary language. Patients were required to complete all components of the t-MoCA for scoring, and incomplete assessments or surrogate responses were excluded from analyses. Patients were required to complete the t-MoCA by themselves without surrogate assistance.

The t-MoCA consists of 22 items divided into the domains of attention (6 points, 3 items: digits forwards and backwards, identifying a target in a series, and serial subtraction), language (2 points, 1 item: sentence repetition), memory (5 points, 3-trial recall of 5 items with short-term uncued delayed recall), executive function (3 points, 2 items: verbal abstraction, categorical verbal fluency) and orientation (6 points, assessment of orientation to time and place) 43 . The score is total points earned plus an additional point given for those with ≤12 years of education 44 .

Anxiety and depression symptoms were measured to assess for confounding of cognitive outcomes due to psychiatric comorbidities with the Quality of Life in Neurological Disorders 45 (Neuro-QoL) short form self-reported health measures of depression and anxiety. Neuro-QoL raw scores were converted into T-scores with a mean of 50 and standard deviation of 10 in a reference population (U.S. general population or clinical sample); T-scores ≥60 were considered abnormal (mean+1SD). Higher T-scores indicate worse self-reported depression or anxiety.

demographic variables, SDoH, premorbid medical comorbidities, clinical data, peri-COVID neurological complications, medical complications, medications administered during hospitalization, and in-hospital outcomes using the Mann-Whitney U test for non-normally distributed continuous variables and Chi-squared or Fisher's exact test, as appropriate, for categorical values. Multivariable, backward, step-wise logistic regression models were constructed to identify independent predictors of t-MoCA impairment 6-months post hospitalization utilizing univariate variables associated with p values<0.100. Patients with a baseline history of dementia or cognitive abnormality were excluded from multivariable analysis.

All interactions were tested.

Domains of cognitive dysfunction were compared between patients with and without neurological complications during index hospitalization and among subgroups with significantly higher rates of t-MoCA impairment using Mann-Whitney U tests.

Correlation of t-MoCA scores and NeuroQoL depression and anxiety scores was assessed using Spearman's correlation coefficients. Statistical significance was set at P<0.05. All analyses were conducted using IBM SPSS Statistics for Mac version 25 (IBM Corp., Armonk, NY).

and NeuroQoL depression (Spearman's rho= -0.82, p=0.240) or anxiety (Spearman's rho= -0.001, p=0.988) scores measured 6-months post discharge.

In multivariable logistic regression analysis, excluding patients with a pre-COVID history of dementia and after adjusting for univariate predictors of 6-month t-MoCA impairment ( We next evaluated individual t-MoCA cognitive domains (Tables 3 and 4 ). Overall, memory was the area of weakest performance, with only 14% of respondents achieving the maximum possible score, but without significant difference between those patients with and without neurological complications during hospitalization. However, those with neurological complications scored significantly worse than those without in the domains of attention and language (Table 3) . Comparing Black respondents to other races, scores in the domains of attention, memory and executive functioning were significantly lower, while those with lower levels of education scored lower in these domains as well as the language domain (Table 4 ).

Patients who were unemployed prior to COVID hospitalization demonstrated abnormalities across all domains of attention, language, memory, executive function and orientation (Table 4) .

In this study, we found that Black race, fewer years of formal education, and prehospitalization unemployment in the context of disability may be significant predictors of cognitive dysfunction as measured by the t-MoCA 6-months after hospitalization for COVID-19, even after adjusting for other factors. Contrary to our expectation, we found that cognitive impairment was independent of any hospital metric or recorded measure of illness severity including ventilator status, Sequential Organ Failure Assessment (SOFA) scores [46] [47] [48] , inpatient medications, inflammatory markers, medical or neurological complications, and discharge disposition. This may be because the most severely ill patients either died in-hospital or were too impaired to complete the 6-month the t-MoCA assessment. Strengths of our study include its prospective ascertainment of data, self-reported race/ethnicity and employment status, a large sample size, initial neurological diagnoses by board-certified neurologists, adjustment for multiple possible confounders of cognitive dysfunction, and assessment of alterations in cognition that could be due to depression or anxiety.

Health disparities, including increased rates of SARS-CoV-2 infection, increased severity of illness and increased mortality have been reported among racial/ethnic minority groups, particularly among Black and Latinx populations 25, 49 . Traditionally, racial health disparities for general medical conditions have been ascribed to differences in rates of chronic medical conditions, such as diabetes, hypertension, chronic kidney disease or smoking. However, we found that worse cognitive scores were independent of premorbid conditions that are found at J o u r n a l P r e -p r o o f higher rates in Black and Latinx populations, including hypertension, diabetes, obesity and chronic kidney disease. Furthermore, we did not detect any differences in baseline demographics, education, health insurance status, or employment status between Black and non-Black patients, apart from income level as estimated by zip code. This finding is important because it not only implies the significant role that financial status may play in health outcomes, but also suggests regional community variability in health outcomes. However, in multivariable analysis, even after controlling for household income/zip code, Black patients still had worse cognitive outcomes than other race groups, suggesting that additional unmeasured factors are at play. Previous studies have shown an increased risk of testing positive for COVID-19 among Black and Latinx patients compared with White patients 25 . This suggests that differences in exposure to SARS-CoV-2 and access to outpatient care post hospitalization between race groups may also impact cognitive outcomes. For example, we did not collect data on certain SDOH such as access to outpatient care post-hospitalization, which may impact cognitive outcomes.

Studies have found that lower MOCA cut-points among Black and Latinx patients compared to non-Latinx White patients have better positive and negative predictive value for the clinical diagnoses of mild cognitive impairment and Alzheimer's Disease 50 . Therefore, it is also possible that there are biases intrinsic to the t-MOCA test that could unfairly impact different race/ethnic groups. Compared to the full MOCA, the shorter t-MOCA has been found to have reasonable, albeit less sensitive and specific, discriminative ability for detecting mild cognitive impairment or dementia across demographically diverse racial/ethnic populations independent of age, education level, depressive symptoms, and/or issues with telephone administration 51 .

However, since the standard MOCA has been found to have varying levels of discrimination between mild cognitive impairment (MCI), normal aging, and dementia in Black and Latinx J o u r n a l P r e -p r o o f populations 52 , it is possible that our results are affected by unmeasured testing biases that are specific to Black populations.

Another possible explanation may be that the biological effects of COVID-19 differ based upon genetic differences encountered in different racial/ethnic groups 53, 54 . For example, genes regulating SARS-CoV-2 uptake, endosomal trafficking and cytokine signaling are differentially expressed in Black Americans compared to European White Americans with COVID-19 55 , which may contribute to more severe COVID-19 symptoms and worse cognitive outcomes among Black patients. However, we did not detect any differences in severity of COVID-19 illness (e.g. intubation status, oxygen or blood pressure nadirs, or SOFA scores) between patients with or without abnormal 6-month t-MoCA scores or between Black and non-Black patients. This suggests that the genetic differences that have been identified, thus far 55 , may not be clinically significant and that biological effects may not be the primary drivers of the observed differences in cognitive performance by race. Rather, social and economic disparities, nutritional variability 56 , and systematic discriminatory environments may be contributing to observed cognitive differences. Apart from COVID-19, it is notable that the incidence of dementia, in general, in the U.S. is highest in Black Americans and Native Americans/Native

Americans, after adjusting for age, sex, medical utilization and comorbidities 57 . Current literature suggests that this increased risk of dementia among Black individuals is more likely attributed to pervasive social inequities and racially related life-course factors, such as differences in education attainment, access to material and social resources, exposure to discrimination, and exposure to neurotoxins, rather than genetic predisposition 58 .

The higher likelihood of cognitive impairment among patients with fewer years of formal education in our study was expected, given the well-established relationship between low education attainment and cognitive impairment 59 . This may be because individuals with more education possess a greater cognitive reserve and capacity to recruit eloquent brain regions, which allows them to sustain a larger degree of brain pathology before clinical impairment becomes apparent 59 . Though we adjusted for education level, there is no validated way to adjust for quality of education, which varies widely across metropolitan NYC 60 This study has limitations. First, we excluded patients with mild COVID-19 disease that was not severe enough to warrant hospitalization, which limits the generalizability of our findings to patients with mild COVID-19. Conversely, the most severely affected patients with profound deficits in cognition or level of alertness were unable to complete the t-MOCA, so we likely have underestimated the percentage of hospital survivors with abnormal cognition.

Deficits in attention may also affect patients' ability to complete the t-MOCA, resulting in lower scores in all other cognitive domains. Though we accounted for baseline history of dementia and baseline mRS, it is possible that some patients had undiagnosed cognitive disorders. Indeed, patients who had worse baseline mRS and were unemployed before hospitalization for COVID-J o u r n a l P r e -p r o o f disability (as measured by the mRS), which was severe enough to preclude employment, also contributed to undiagnosed pre-COVID cognitive dysfunction. Despite this, the estimated prevalence of mild cognitive impairment in the general community among patients aged 65-69 years (the median age of our population) is only 8.4% 66 and the prevalence of dementia is <1% 67 , suggesting that undiagnosed cognitive impairment is likely uncommon. Although our cohort derives from a large, diverse catchment area, it may not be representative of observations made in other parts of the country. Our screening for depression and anxiety with the Neuro-QoL batteries did not indicate that emotional distress contributed to the current findings. However, our study was limited by the use of this brief self-reported screening measure. We note also that rates of reported psychiatric history among Black patients in our sample were lower than would be expected. Underreporting of psychiatric illness, as well as concerns about prejudice and discrimination related to psychiatric diagnoses, have been shown to vary by race/ethnicity and gender [68] [69] [70] . Given the emotional distress that can occur with COVID-19 illness, future studies should include a more comprehensive measurement of emotional health. Finally, lack of a SARS-CoV-2 negative control group in our study limits our ability to determine if cognitive deficits are a direct consequence of SARS-CoV-2 infection. Despite this limitation, we did adjust for confounders and serious abnormalities were identified in patients with no history of cognitive impairment, suggesting that either SARS-CoV-2 or its secondary complications may be implicated in the development of abnormal cognition.

Our study suggests that Black race, fewer years of education, and pre-hospitalization unemployment in the context of disability may predict worse cognitive performance, as measured by the t-MOCA, 6 months after hospitalization with COVID-19. To better characterize the nature and implications of these findings, future studies utilizing more extensive cognitive batteries in diverse populations with and without COVID-19 are needed. Such studies may guide future interventions and treatments to improve cognitive outcomes following hospitalization with COVID-19. J o u r n a l P r e -p r o o f 

COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience

Cognitive profile following COVID-19 infection: Clinical predictors leading to neuropsychological impairment

Cognitive assessment in asymptomatic COVID-19 subjects

Pattern of cognitive deficits in severe COVID-19

Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: A longitudinal prospective study nested to a population cohort

Prolonged Neuropsychological Deficits, Central Nervous System Involvement, and Brain Stem Affection After COVID-19-A Case Series

Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients

Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19

Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables

Neuropsychological Features of Severe Hospitalized Coronavirus Disease 2019 Patients at Clinical Stability and Clues for Postacute Rehabilitation

Neurocognitive deficits in severe COVID-19 infection: Case series and proposed model

Frequent neurocognitive deficits after recovery from mild COVID-19

Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications

A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications

Toxic Metabolic Encephalopathy in Hospitalized Patients with COVID-19

Measurement of Health Disparities, Health Inequities, and Social Determinants of Health to Support the Advancement of Health Equity

Effect of Social Determinants of Health on Cognition and Risk of Alzheimer Disease and Related Dementias

Assessing the impact of social determinants of health on predictive models for potentially avoidable 30-day readmission or death

Prevalence and Predictors of Prolonged Cognitive and Psychological Symptoms Following COVID-19 in the United States

The Social Brain and Emotional Contagion: COVID-19 Effects

Hospitalization and Mortality among Black Patients and White Patients with Covid-19

Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in

Social determinants of COVID-19 incidence and outcomes: A rapid review

The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America

Practice guidelines for the management of bacterial meningitis

Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium

Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis

Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association/American Stroke Association

Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria

Neurophysiological criteria in the diagnosis of different clinical types of Guillain-Barre syndrome

Guillain-Barre syndrome and Fisher syndrome: case definitions and guidelines for collection, analysis, and presentation of immunization safety data

Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale

Impact of socioeconomic status measures on hospital profiling in New York City

Telephone assessment of cognition after transient ischemic attack and stroke: modified telephone interview of cognitive status and telephone Montreal Cognitive Assessment versus face-to-face Montreal Cognitive Assessment and neuropsychological battery

Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample

Neuro-QOL: brief measures of health-related quality of life for clinical research in neurology

Serial evaluation of the SOFA score to predict outcome in critically ill patients

The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine

COVID-19 and Racial/Ethnic Disparities

Montreal Cognitive Assessment vary by race and ethnicity

Discriminative Ability of Montreal Cognitive Assessment Subtests and Items in Racial and Ethnic Minority Groups

The Perfect Storm: COVID-19 Health Disparities in US Blacks

African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures

COVID-19: Role of Nutrition and Supplementation

Inequalities in dementia incidence between six racial and ethnic groups over 14 years

Cognitive Aging in Black and White Americans: Cognition, Cognitive Decline, and Incidence of Alzheimer Disease Dementia

Relationship between education and age-related cognitive decline: a review of recent research

School Quality Reports and Resources

Long Hauler

Impact on health and provision of healthcare services during the COVID-19 lockdown in India: a multicentre cross-sectional study

The landscape of cognitive function in recovered COVID-19 patients

Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study

Preliminary Validation of the Montreal Cognitive Assessment Tool among Sepsis Survivors: A Prospective Pilot Study

Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Racial/Ethnic and Gender Disparities in Health Care Use and Access

Trends in Racial-Ethnic Disparities in Access to Mental Health Care

Stigma: barrier to mental health care among ethnic minorities